Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Public ClinicalTrials.gov record NCT03282591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study of the efficacy, safety, and tolerability of serlopitant for the treatment of refractory chronic cough
Study identification
- NCT ID
- NCT03282591
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 185 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 3, 2017 (Actual)
- Primary completion
- Aug 15, 2018 (Actual)
- Completion
- Sep 6, 2018 (Actual)
- Last update posted
- May 20, 2021
2017 – 2018
United States locations
- U.S. sites
- 29
- U.S. states
- 14
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Site 130 | Los Angeles | California | 90048 | — |
| Study Site 128 | Mission Viejo | California | 92691 | — |
| Study Site 123 | San Diego | California | 92108 | — |
| Study Site 127 | San Jose | California | 95117 | — |
| Study Site 131 | Stockton | California | 95207 | — |
| Study Site 106 | Colorado Springs | Colorado | 80907 | — |
| Study Site 113 | Colorado Springs | Colorado | 80907 | — |
| Study Site 108 | Denver | Colorado | 80230 | — |
| Study Site 118 | Largo | Florida | 33778 | — |
| Study Site 107 | Winter Park | Florida | 32789 | — |
| Study Site 115 | Plymouth | Minnesota | 55441 | — |
| Study Site 110 | Rochester | Minnesota | 55905 | — |
| Study Site 121 | Ocean Township | New Jersey | 07712 | — |
| Study Site 125 | Rochester | New York | 14618 | — |
| Study Site 129 | Charleston | North Carolina | 29420 | — |
| Study Site 103 | Charlotte | North Carolina | 28207 | — |
| Study Site 111 | Gastonia | North Carolina | 28054 | — |
| Study Site 114 | Mooresville | North Carolina | 28117 | — |
| Study Site 122 | Cincinnati | Ohio | 45231 | — |
| Study Site 112 | Tulsa | Oklahoma | 74136 | — |
| Study Site 117 | Eugene | Oregon | 97401 | — |
| Study Site 116 | Portland | Oregon | 97202 | — |
| Study Site 104 | Rock Hill | South Carolina | 29732 | — |
| Study Site 102 | Dallas | Texas | 75231 | — |
| Study Site 120 | Dallas | Texas | 75231 | — |
| Study Site 101 | San Antonio | Texas | 78229 | — |
| Study Site 109 | Waco | Texas | 76712 | — |
| Study Site 126 | Bellingham | Washington | 98225 | — |
| Study Site 105 | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03282591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03282591 live on ClinicalTrials.gov.